Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J7171 Injection, adzynma, 10 iu

J Codes (Drugs)

Also known as: Adzynma, long-acting Factor VIII, pegylated Factor VIII

Injection of Adzynma (antihemophilic factor [recombinant], porcine sequence, pegylated), a long-acting recombinant Factor VIII, supplied as 10 International Units per dose.

In Plain Language

hemophilia A treatment; clotting factor replacement

Clinical Context

Used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A patients, benefits from extended half-life reducing injection frequency.

RVU Information

CPT J7171 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

HematologyHemophilia Specialty ClinicPediatrics

Frequently Asked Questions

What is CPT code J7171?

CPT J7171 (Injection, adzynma, 10 iu) is a J Codes (Drugs) code. Injection of Adzynma (antihemophilic factor [recombinant], porcine sequence, pegylated), a long-acting recombinant Factor VIII, supplied as 10 International Units per dose.

How is J7171 administered?

CPT J7171 is administered by a healthcare provider, typically via injection or infusion. Used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A patients, benefits from extended half-life reducing injection frequency. It is used by Hematology, Hemophilia Specialty Clinic, Pediatrics.

When is CPT J7171 used?

Used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in hemophilia A patients, benefits from extended half-life reducing injection frequency.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.